October 27, 2005

PALADIN REPORTS RECORD REVENUE FOR THIRD QUARTER
(Also in PDF format)

October 26, 2005

PALADIN AND DURAMED SIGN SEASONALE PRODUCT CANADIAN LICENSE AND DISTRIBUTION AGREEMENT
(Also in PDF format)

October 20, 2005

NOTICE OF PALADIN LAB'S THIRD QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

September 22, 2005

PALADIN LABS ANNOUNCES CANADIAN LAUNCH OF TWINJECT FOR ANAPHYLAXIS
(Also in PDF format)

August 16, 2005

PALADIN LABS TO ACQUIRE CANADIAN LICENSE TO PENNSAID
(Also in PDF format)

July 28, 2005

PALADIN REPORTS 2005 SECOND QUARTER RESULTS
(Also in PDF format)

July 27, 2005

PALADIN LABS ANNOUNCES AGREEMENT WITH VERUS PHARMACEUTICALS FOR COMMERCIALIZATION OF TWINJECT IN CANADA
(Also in PDF format)

July 21, 2005

NOTICE OF PALADIN LABS SECOND QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

June 16, 2005

HEALTH CANADA REQUESTS ADDITIONAL INFORMATION ON VANTAS® NEW DRUG SUBMISSION
(Also in PDF format)

May 5, 2005

PALADIN REPORTS 2005 FIRST QUARTER FINANCIAL RESULTS
(Also in PDF format)

May 2, 2005

PALADIN AND WATSON ENTER INTO MARKETING AND SUPPLY AGREEMENT FOR TRELSTAR^® IN CANADA
(Also in PDF format)

April 28, 2005

NOTICE OF PALADIN LAB'S FIRST QUARTER RESULTS CONFERENCE CALL
(Also in PDF format)

April 20, 2005

HEALTH CANADA GIVES CANADIAN WOMEN A PLAN B
(Also in PDF format)

March 29, 2005

PALADIN APPOINTS VICE-PRESIDENT, REGULATORY AFFAIRS, DRUG SAFETY AND MEDICAL SERVICES
(Also in PDF format)

February 17, 2005

PALADIN REPORTS 2004 FOURTH QUARTER AND YEAR END RESULTS
(Also in PDF format)

February 17, 2005

PALADIN ANNOUNCES NORMAL COURSE ISSUER BID
(Also in PDF format)

February 10, 2005

NOTICE OF PALADIN LAB'S 2004 YEAR-END RESULTS CONFERENCE CALL
(Also in PDF format)

February 5, 2005

PALADIN ANNOUNCES IMPORTANT MILESTONE IN LAUNCH OF OXYTROL®
(Also in PDF format)